Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Operating Income
Dexcom Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Operating Income
$614.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Dexcom Inc's Operating Income?
Operating Income
614.3m
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Operating Income amounts to 614.3m USD.
What is Dexcom Inc's Operating Income growth rate?
Operating Income CAGR 3Y
24%
Over the last year, the Operating Income growth was 52%. The average annual Operating Income growth rates for Dexcom Inc have been 24% over the past three years .